GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist

NCT04238936 · clinicaltrials.gov ↗
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital